Biomarkers Market Size, Share, Trends, Growth 2032

Biomarkers Market

Biomarkers Market By Biomarker Type (Safety, Efficacy, and Validation), By Application (Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), and By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, and Others), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 - 2032

Category: Biotechnology Report Format : PDF Pages: 215 Report Code: ZMR-4750 Published Date: Apr-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 67.41 Billion USD 237.15 Billion 15.00% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Biomarkers Market, 2016-2025 (USD Billion)
    • 2.2. Global Biomarkers Market: Snapshot
  •  
  • Chapter 3. Biomarkers Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of chronic diseases
      • 3.2.2. Technological advancements
    • 3.3. Market Restraints
      • 3.3.1. Reimbursement policies
    • 3.4. Opportunities
      • 3.4.1. Growing Funding for biomarkers
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by Biomarker Type
      • 3.6.2. Market attractiveness analysis, by Application
      • 3.6.3. Market attractiveness analysis, by Disease
      • 3.6.4. Market attractiveness analysis, by Region
  •  
  • Chapter 4. Global Biomarkers Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Biomarkers Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Biomarkers Market - Biomarker Type Analysis
    • 5.1. Global Biomarkers Market: Biomarker Type overview
      • 5.1.1. Global Biomarkers Market Revenue, by Biomarker Type, 2018 and 2025
    • 5.2. Safety Biomarkers
      • 5.2.1. Global Biomarkers Market for Safety Biomarkers, 2016-2025 (USD Billion)
    • 5.3. Efficacy Biomarkers
      • 5.3.1. Global Biomarkers Market for Efficacy Biomarkers, 2016-2025 (USD Billion)
    • 5.4. Validation Biomarkers
      • 5.4.1. Global Biomarkers Market for Validation Biomarkers, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Biomarkers Market - Application Analysis
    • 6.1. Global Biomarkers Market: Application overview
      • 6.1.1. Global Biomarkers Market Revenue, by Application, 2018 and 2025
    • 6.2. Diagnostic
      • 6.2.1. Global Biomarkers Market for Diagnostic, 2016-2025 (USD Billion)
    • 6.3. Drug Development
      • 6.3.1. Global Biomarkers Market for Drug Development, 2016-2025 (USD Billion)
    • 6.4. Personalized Medicine
      • 6.4.1. Global Biomarkers Market for Personalized Medicine, 2016-2025 (USD Billion)
    • 6.5. Others
      • 6.5.1. Global Biomarkers Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Biomarkers Market - Disease Analysis
    • 7.1. Global Biomarkers Market: Disease overview
      • 7.1.1. Global Biomarkers Market Revenue, by Disease, 2018 and 2025
    • 7.2. Cancer
      • 7.2.1. Global Biomarkers Market for Cancer, 2016-2025 (USD Billion)
    • 7.3. Cardiovascular Diseases
      • 7.3.1. Global Biomarkers Market for Cardiovascular Diseases, 2016-2025 (USD Billion)
    • 7.4. Neurological Diseases
      • 7.4.1. Global Biomarkers Market for Neurological Diseases, 2016-2025 (USD Billion)
    • 7.5. Immunological Diseases
      • 7.5.1. Global Biomarkers Market for Immunological Diseases, 2016-2025 (USD Billion)
    • 7.6. Others
      • 7.6.1. Global Biomarkers Market for Others, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Biomarkers Market- Regional Segment Analysis
    • 8.1. Global Biomarkers Market: regional overview
      • 8.1.1. Global Biomarkers Market Revenue, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
      • 8.2.2. North America Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.2.3. North America Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.2.4. The U.S.
        • 8.2.4.1. The U.S. Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.2.4.2. The U.S. Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.2.4.3. The U.S. Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.2.5. Canada
        • 8.2.5.1. Canada Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.2.5.2. Canada Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.2.5.3. Canada Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
      • 8.3.2. Europe Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.3.3. Europe Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.3.4. The U.K.
        • 8.3.4.1. U.K. Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.3.4.2. U.K. Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.4.3. U.K. Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.3.5. Germany
        • 8.3.5.1. Germany Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.3.5.2. Germany Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.5.3. Germany Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.3.6.2. France Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.6.3. France Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.3.7. Rest of Europe
        • 8.3.7.1. Rest of Europe Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.3.7.2. Rest of Europe Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.3.7.3. Rest of Europe Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
      • 8.4.2. Asia Pacific Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.4.3. Asia Pacific Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.4.4. China
        • 8.4.4.1. China Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.4.4.2. China Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.4.3. China Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.4.5. Japan
        • 8.4.5.1. Japan Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.4.5.2. Japan Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.5.3. Japan Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.4.6. India
        • 8.4.6.1. India Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.4.6.2. India Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.6.3. India Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.4.7.2. Rest of Asia Pacific Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.4.7.3. Rest of Asia Pacific Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
      • 8.5.2. Latin America Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.5.3. Latin America Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.5.4.2. Brazil Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.5.4.3. Brazil Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
      • 8.5.5. Rest of Latin America
        • 8.5.5.1. Rest of Latin America Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
        • 8.5.5.2. Rest of Latin America Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
        • 8.5.5.3. Rest of Latin America Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Biomarkers Market Revenue, by Biomarker Type, 2016-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa Biomarkers Market Revenue, by Application, 2016-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa Biomarkers Market Revenue, by Disease, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Agilent Technologies
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Therapy portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. F. Hoffmann-La Roche
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Therapy portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Epigenomics
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Therapy portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Abbott
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Therapy portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Thermo Fisher Scientific
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Therapy portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Johnson & Johnson
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Therapy portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Siemens Healthcare
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Therapy portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Bio-Rad Laboratories
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Therapy portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments
    • 9.9. Qiagen
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Therapy portfolio
      • 9.9.4. Business strategy
      • 9.9.5. Recent developments

Table Of Figures

List of Figures

1. Market Research Process
2. Market Research Methodology
3. Global Biomarkers Market Revenue, 2016–2025 (USD Billion) 
4. Porter’s Five Forces Analysis
5. Biomarkers Market attractiveness analysis, by Biomarker Type
6. Biomarkers Market attractiveness analysis, by Application
7. Biomarkers Market attractiveness analysis, by Disease
8. Biomarkers Market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global Biomarkers Market Revenue by Biomarker Type, 2018 and 2025
11. Global Biomarkers Market for Safety Biomarkers, 2016–2025 (USD Billion) 
12. Global Biomarkers Market for Efficacy Biomarkers, 2016–2025 (USD Billion) 
13. Global Biomarkers Market for Validation Biomarkers, 2016–2025 (USD Billion) 
14. Global Biomarkers Market share by Application, 2018 and 2025
15. Global Biomarkers Market for Diagnostic, 2016–2025 (USD Billion) 
16. Global Biomarkers Market for Drug Discovery & Development, 2016–2025 (USD Billion) 
17. Global Biomarkers Market for Personalized Medicine, 2016–2025 (USD Billion) 
18. Global Biomarkers Market for Others, 2016–2025 (USD Billion) 
19. Global Biomarkers Market Revenue by Disease, 2018 and 2025
20. Global Biomarkers Market for Cancer, 2016–2025 (USD Billion) 
21. Global Biomarkers Market for Cardiovascular Diseases, 2016–2025 (USD Billion)  
22. Global Biomarkers Market for Neurological Diseases, 2016–2025 (USD Billion) 
23. Global Biomarkers Market for Immunological Diseases, 2016–2025 (USD Billion) 
24. Global Biomarkers Market for Others, 2016–2025 (USD Billion) 
25. Global Biomarkers Market Revenue by Region, 2018 and 2025
26. North America Biomarkers Market, 2016–2025 (USD Billion) 
27. Europe Biomarkers Market, 2016–2025 (USD Billion) 
28. Asia Pacific Biomarkers Market, 2016–2025 (USD Billion) 
29. Latin America Biomarkers Market, 2016–2025 (USD Billion) 
30. The Middle East and Africa Biomarkers Market, 2016–2025 (USD Billion) 


Table Of Tables

List of Tables

1. Biomarkers Market: Snapshot
2. Drivers of the global Biomarkers Market: impact analysis 
3. Restraints of the global Biomarkers Market: impact analysis  
4. North America Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
5. North America Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
6. North America Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
7. The U.S. Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
8. The U.S. Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
9. The U.S. Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
10. Canada Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
11. Canada Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
12. Canada Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
13. Europe Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
14. Europe Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
15. Europe Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
16. U.K. Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
17. U.K. Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
18. U.K. Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
19. Germany Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
20. Germany Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
21. Germany Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
22. France Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
23. France Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
24. France Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
25. Rest of Europe Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
26. Rest of Europe Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
27. Rest of Europe Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
28. Asia Pacific Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
29. Asia Pacific Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
30. Asia Pacific Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
31. China Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
32. China Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
33. China Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
34. Japan Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
35. Japan Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
36. Japan Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
37. India Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
38. India Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
39. India Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
40. Rest of Asia Pacific Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
41. Rest of Asia Pacific Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
42. Rest of Asia Pacific Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
43. Latin America Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
44. Latin America Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
45. Latin America Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
46. Brazil Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
47. Brazil Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
48. Brazil Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
49. Rest of Latin America Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
50. Rest of Latin America Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
51. Rest of Latin America Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion) 
52. The Middle East and Africa Biomarkers Market Revenue, by Biomarker Type, 2016–2025 (USD Billion) 
53. The Middle East and Africa Biomarkers Market Revenue, by Application, 2016–2025 (USD Billion) 
54. The Middle East and Africa Biomarkers Market Revenue, by Disease, 2016–2025 (USD Billion)

Methodology

FrequentlyAsked Questions

Biomarkers are quantifiable attributes or characteristics that can be assessed impartially and employed to monitor biological processes, disease conditions, or treatment responses. They may consist of molecules, genes, proteins, organisms, or other biological substances. Biomarkers are of paramount importance across multiple disciplines, such as medicine, biology, and environmental science, as they furnish vital insights into the state of health, the advancement of diseases, and the effectiveness of treatments.
 

Technological advancements, including but not limited to next-generation sequencing, advanced imaging technologies, and high-throughput screening techniques, facilitate the identification and verification of novel biomarkers with enhanced precision and efficacy. The proliferation of these technological advancements stimulates the biomarkers market by broadening the assortment of biomarkers accessible for diverse applications.
 

The global biomarkers market size was worth around USD 67.41 billion in 2023 and is predicted to grow to around USD 237.15 billion by 2032.

The global biomarkers market with a compound annual growth rate (CAGR) of roughly 15.00% between 2024 and 2032.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players in the global biomarkers market are Agilent Technologies, F. Hoffmann-La Roche, Epigenomics, Abbott, Thermo Fisher Scientific, Johnson & Johnson, Siemens Healthcare, Bio-Rad Laboratories, and Qiagen.

Choose License Type

  • zion payment modes

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed